Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Mistrust and barriers to influenza vaccination are well-documented in the literature. Underserved populations, including the Hispanic community, experience social determinants of health that exacerbate their health outcomes, including for common preventable illnesses such as influenza (flu). There is currently a gap in the literature regarding the knowledge, barriers to access, and trust of the Hispanic community regarding the influenza vaccine. The objective of this study was to assess knowledge, barriers to access, and trust regarding the influenza vaccine among Hispanic individuals in Metro Detroit. We administered a descriptive, mixed quantitative and qualitative survey, including predominantly Likert-style statements, to nearly 120 Hispanic individuals in Metro Detroit during the influenza seasons of 2023 and 2024 at our clinic and in public community spaces to assess these three domains. We also gathered information regarding demographics and previous vaccination history. These surveys were completed both via interviewer-administered and self-reported formats. For analysis, Likert-type items were collapsed, Chi-squared tests were performed, and the significance threshold was set at p <0.05. Findings included average knowledge of the vaccine, as 34% of individuals agreed they did not need the flu vaccine if they got it the prior year, while 44% of individuals disagreed. Trust in the vaccine was high, as 67% of respondents felt government influenza vaccination programs were trustworthy. Few overall barriers to vaccination were reported, as insurance was only reported by 19% as a barrier, while time was cited as the most common self-reported barrier by 51% of respondents. Subgroup analysis showed that, on average, males and younger individuals were less likely to trust influenza vaccines. Further research is needed to address time-related barriers and increase vaccine knowledge and trust through community initiatives. Such efforts will lead to improved vaccination rates and influenza outcomes for all Hispanic individuals.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12398302PMC
http://dx.doi.org/10.7759/cureus.89068DOI Listing

Publication Analysis

Top Keywords

influenza vaccine
12
knowledge barriers
12
hispanic community
12
metro detroit
12
trust hispanic
8
barriers access
8
access trust
8
hispanic individuals
8
individuals metro
8
hispanic
5

Similar Publications

Aims: Atrial fibrillation (AF) may be associated with adverse influenza-related outcomes. We assessed the relative vaccine effectiveness (rVE) of high-dose (HD-IIV) vs. standard-dose (SD-IIV) inactivated influenza vaccination against cardiovascular and all-cause hospitalizations and all-cause mortality according to history of AF.

View Article and Find Full Text PDF

Overview: We analysed Australian Immunisation Register (AIR) data, predominantly for National Immunisation Program funded vaccines, as at 2 April 2023 for children, adolescents and adults, focusing on the calendar year 2022 and on trends from previous years. This report aims to provide comprehensive analysis and interpretation of vaccination coverage data to inform immunisation policy and programs.

Children: Fully vaccinated coverage in Australian children in 2022 was 0.

View Article and Find Full Text PDF

Influenza virus neuraminidase (NA) is a crucial target for protective antibodies, yet the development of recombinant NA protein as a vaccine has been held back by instability and variable expression. We have taken a pragmatic approach to improving expression and stability of NA by grafting antigenic surface loops from low-expressing NA proteins onto the scaffold of high-expressing counterparts. The resulting hybrid proteins retained the antigenic properties of the loop donor while benefiting from the high-yield expression, stability, and tetrameric structure of the loop recipient.

View Article and Find Full Text PDF

Chronic obstructive pulmonary disease (COPD) is a prevalent respiratory condition associated with increased morbidity and mortality, particularly during respiratory infections such as influenza. The interaction between COPD and influenza is multifaceted, involving compromised immune responses, chronic inflammation, and impaired lung function. Influenza infection can exacerbate COPD, leading to acute exacerbations, hospitalizations, and higher mortality.

View Article and Find Full Text PDF

Background: Few studies have evaluated COVID-19 vaccine effectiveness (VE) in middle-income countries, particularly in eastern Europe. We aimed to estimate COVID-19 VE against SARS-CoV-2-confirmed hospitalizations and severe outcomes in Kosovo.

Methods: We conducted a test-negative case-control study using data from Kosovo's severe acute respiratory infection (SARI) sentinel surveillance system from January 2022 to June 2024.

View Article and Find Full Text PDF